# A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis

> **NCT02475772** · PHASE1 · COMPLETED · sponsor: **Clemens Tempfer** · enrollment: 15 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Cisplatin and doxorubicin
- **PROCEDURE:** Cisplatin and doxorubicin

## Key facts

- **NCT ID:** NCT02475772
- **Lead sponsor:** Clemens Tempfer
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02475772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02475772, "A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02475772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*